Education
About Us
Working with TipRanks
Follow Us
BioSig Technologies Inc (BSGM)
NASDAQ:BSGM
BSGM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.23 - $14.11
Previous CloseN/A
Volume81.57K
Average Volume (3M)785.59K
Market Cap
$155.54M
Enterprise Value$8.96M
Total Cash (Recent Filing)$2.82M
Total Debt (Recent Filing)$15.00K
Price to Earnings (P/E)―
Beta1.02
Next Earnings
May 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding35,270,943
10 Day Avg. Volume606,323
30 Day Avg. Volume785,587
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.06
Enterprise Value/Revenue689.59
Enterprise Value/Gross Profit-498.04
Enterprise Value/Ebitda-0.32
Forecast
1Y Price Target
$10.00Price Target Upside126.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Bulls Say, Bears Say
Bulls Say
AcquisitionThe acquisition of Streamex Exchange Corp. is seen as a move to bridge the gap between traditional finance and the digital economy, enhancing liquidity, accessibility, and efficiency.
Market OpportunityStreamex's focus on real-world asset tokenization in the commodities space presents a market opportunity believed to have a billion dollars market potential.
ValuationThe current valuation of the company is considered attractive, with a significant upside potential from the current share price, leading to a raised 12-month price target.
Bears Say
Financial StabilityThe company has ~$0 in cash and ~$0 million in debt and needs to raise new capital soon if it wants to resume business.
GuidanceThe company did not provide forward guidance.
ReorganizationThe company announced a major reorganization in which it terminated a significant number of its employees and substantially reduced business operations due to lack of capital.
BioSig Technologies News
BSGM FAQ
What was BioSig Technologies Inc’s price range in the past 12 months?
BioSig Technologies Inc lowest stock price was $0.23 and its highest was $14.11 in the past 12 months.
What is BioSig Technologies Inc’s market cap?
BioSig Technologies Inc’s market cap is $155.54M.
When is BioSig Technologies Inc’s upcoming earnings report date?
BioSig Technologies Inc’s upcoming earnings report date is May 18, 2026 which is in 252 days.
How were BioSig Technologies Inc’s earnings last quarter?
BioSig Technologies Inc released its earnings results on May 19, 2025. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.05 by -$0.09.
Is BioSig Technologies Inc overvalued?
According to Wall Street analysts BioSig Technologies Inc’s price is currently Undervalued.
Does BioSig Technologies Inc pay dividends?
BioSig Technologies Inc does not currently pay dividends.
What is BioSig Technologies Inc’s EPS estimate?
BioSig Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioSig Technologies Inc have?
BioSig Technologies Inc has 35,270,943 shares outstanding.
What happened to BioSig Technologies Inc’s price movement after its last earnings report?
BioSig Technologies Inc reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.05. Following the earnings report the stock price went up 8.812%.
Which hedge fund is a major shareholder of BioSig Technologies Inc?
Currently, no hedge funds are holding shares in BSGM
BioSig Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (126.76% Upside)
$10.00 (126.76% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.1%
Last 30 Days ▼ 11.0%
Last 30 Days ▼ 11.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
882.18%
12-Months-Change
Fundamentals
Return on Equity
5400.35%
Trailing 12-Months
Asset Growth
3431.41%
Trailing 12-Months
Company Description
BioSig Technologies Inc
BioSig Technologies, Inc. is a medical technology company that operates in the healthcare sector, focusing on advanced signal processing solutions for the medical industry. The company's core product is the PURE EP System, an innovative platform designed to improve the clarity and precision of cardiac signal data during electrophysiology (EP) procedures. This technology aims to enhance the diagnosis and treatment of complex arrhythmias by providing physicians with clearer, more interpretable data, potentially improving patient outcomes.
Technical Analysis
Accelerate Diagnostics
―
Co-Diagnostics
―
PAVmed
―
Vivos Therapeutics
―
Adagio Medical Holdings
―
Ownership Overview
13.33% Insiders
0.58% Mutual Funds
44.17% Other Institutional Investors
39.60% Public Companies and
Individual Investors